共 25 条
Management of aggressive pituitary adenomas: current treatment strategies
被引:56
作者:

Buchfelder, Michael
论文数: 0 引用数: 0
h-index: 0
机构:
Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany
机构:
[1] Univ Erlangen Nurnberg, Dept Neurosurg, D-91054 Erlangen, Germany
来源:
关键词:
Pituitary adenoma;
Surgery;
Pharmacotherapy;
Radiotherapy;
Chemotherapy;
LONG-TERM;
SOMATOSTATIN ANALOGS;
DOPAMINE AGONISTS;
PRIMARY THERAPY;
TEMOZOLOMIDE;
CABERGOLINE;
MACROPROLACTINOMA;
MACROADENOMAS;
TOLERABILITY;
SHRINKAGE;
D O I:
10.1007/s11102-008-0153-z
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Aggressive pituitary adenomas are notoriously difficult to manage due to their size, invasiveness, speed of growth and high frequency of recurrence. Except for prolactinomas, surgery (usually transsphenoidal but sometimes transcranial) is the first-line option, but re-growth of aggressive tumors is almost inevitable and monitoring and repeat surgery is required to control symptoms. In prolactinomas, dopamine agonists are the first-line treatment and they normalize prolactin levels in most patients even with macroprolactinomas. Somatostatin analogues offer another pharmacotherapy for pituitary adenomas either for primary therapy, pre-operatively to reduce the tumor volume and make it more amenable to surgical removal, or post-surgery to control re-expansion. When surgery and pharmacotherapy fail, radiotherapy is a useful third-line strategy that reduces recurrence, while extreme pituitary adenomas with metastases may potentially be managed with chemotherapy (although more data are needed). A combination of these therapies will be required for aggressive pituitary adenomas and careful follow-up is essential.
引用
收藏
页码:256 / 260
页数:5
相关论文
共 25 条
- [1] Clinical review: The antitumoral effects of somatostatin analog therapy in acromegaly[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2005, 90 (03) : 1856 - 1863Bevan, JS论文数: 0 引用数: 0 h-index: 0机构: Aberdeen Royal Infirm, Dept Endocrinol, Aberdeen AB25 2ZN, Scotland Aberdeen Royal Infirm, Dept Endocrinol, Aberdeen AB25 2ZN, Scotland
- [2] Treatment of prolactin-secreting macroadenomas with the once-weekly dopamine agonist cabergoline[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (06) : 2338 - 2343Biller, BMK论文数: 0 引用数: 0 h-index: 0机构: UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22902 USAMolitch, ME论文数: 0 引用数: 0 h-index: 0机构: UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22902 USAVance, ML论文数: 0 引用数: 0 h-index: 0机构: UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22902 USACannistraro, KB论文数: 0 引用数: 0 h-index: 0机构: UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22902 USADavis, KR论文数: 0 引用数: 0 h-index: 0机构: UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22902 USASimons, JA论文数: 0 引用数: 0 h-index: 0机构: UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22902 USASchoenfelder, JR论文数: 0 引用数: 0 h-index: 0机构: UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22902 USAKlibanski, A论文数: 0 引用数: 0 h-index: 0机构: UNIV VIRGINIA, DEPT MED, CHARLOTTESVILLE, VA 22902 USA
- [3] One-year follow-up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®[J]. CLINICAL ENDOCRINOLOGY, 2004, 60 (06) : 734 - 740Caron, P论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FranceBex, M论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FranceCullen, DR论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FranceFeldt-Rasmussen, U论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FrancePico Alfonso, AM论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FrancePynka, S论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FranceRacz, K论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FranceSchopohl, J论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FranceTabarin, A论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, FranceValimaki, MJ论文数: 0 引用数: 0 h-index: 0机构: CHU Rangueil, Dept Endocrinol, Serv Endocrinol & Malad Metab, F-31403 Toulouse, France
- [4] Long-term and low-dose treatment with cabergoline induces macroprolactinoma shrinkage[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1997, 82 (11) : 3574 - 3579Colao, A论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYDiSarno, A论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYLandi, ML论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYCirillo, S论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYSarnacchiaro, F论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYFacciolli, G论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYPivonello, R论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYCataldi, M论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYMerola, B论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYAnnunziato, L论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALYLombardi, G论文数: 0 引用数: 0 h-index: 0机构: UNIV NAPLES FEDERICO II, DEPT RADIOL, I-80131 NAPLES, ITALY
- [5] Effectiveness and tolerability of slow release lanreotide treatment in active acromegaly[J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1999, 22 (01) : 40 - 47论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Marinò, V论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, Italy Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, Italy论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Di Sarno, A论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, Italy Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyGiaccio, A论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, Italy Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyLombardi, G论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, Italy Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, Italy
- [6] Macroprolactinoma shrinkage during cabergoline treatment is greater in naive patients than in patients pretreated with other dopamine agonists: A prospective study in 110 patients[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (06) : 2247 - 2252Colao, A论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyDi Sarno, A论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyLandi, ML论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyScavuzzo, F论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyCappabianca, P论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyPivonello, R论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyVolpe, R论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyDi Salle, F论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyCirillo, S论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyAnnunziato, L论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, ItalyLombardi, G论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, I-80131 Naples, Italy
- [7] Predictors of tumor shrinkage after primary therapy with somatostatin analogs in acromegaly: A prospective study in 99 patients[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (06) : 2112 - 2118Colao, Annamaria论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, ItalyPivonello, Rosario论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, ItalyAuriemma, Renata S.论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, ItalyBriganti, Francesco论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, ItalyGaldiero, Mariano论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, ItalyTortora, Fabio论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, ItalyCaranci, Ferdinando论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, ItalyCirillo, Sossio论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, ItalyLombardi, Gaetano论文数: 0 引用数: 0 h-index: 0机构: Univ Naples Federico II, Dept Mol & Clin Endocrinol & Oncol, Endocrinol Sect, I-80131 Naples, Italy
- [8] Lanreotide 60 mg, a longer-acting somatostatin analog: Tumor shrinkage and hormonal normalization in acromegaly[J]. Pituitary, 2000, 3 (4) : 231 - 238Cozzi R.论文数: 0 引用数: 0 h-index: 0机构: Division of Endocrinology, Niguarda Hospital Division of Endocrinology, Niguarda Hospital Division of Endocrinology, Niguarda HospitalBarausse M.论文数: 0 引用数: 0 h-index: 0机构: Division of Endocrinology, Niguarda Hospital Division of Endocrinology, Niguarda Hospital Division of Endocrinology, Niguarda HospitalSberna M.论文数: 0 引用数: 0 h-index: 0机构: Division of Neuroradiology, Niguarda Hospital Division of Endocrinology, Niguarda HospitalLodrini A.论文数: 0 引用数: 0 h-index: 0机构: Division of Neurosurgery, Neurologic Institute Carlo Besta, Milan Division of Endocrinology, Niguarda HospitalFranzini A.论文数: 0 引用数: 0 h-index: 0机构: Division of Neurosurgery, Neurologic Institute Carlo Besta, Milan Division of Endocrinology, Niguarda HospitalLasio G.论文数: 0 引用数: 0 h-index: 0机构: Division of Neurosurgery, Neurologic Institute Carlo Besta, Milan Division of Endocrinology, Niguarda HospitalAttanasio R.论文数: 0 引用数: 0 h-index: 0机构: Division of Endocrinology, Niguarda Hospital Division of Endocrinology, Niguarda Hospital Division of Endocrinology, Niguarda Hospital
- [9] Long-term response of pituitary carcinoma to temozolomide - Report of two cases[J]. JOURNAL OF NEUROSURGERY, 2006, 105 (04) : 621 - 626Fadul, Camilo E.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Dept Med, Lebanon, NH 03756 USAKominsky, Andrew L.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Dept Med, Lebanon, NH 03756 USAMeyer, Louise P.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Dept Med, Lebanon, NH 03756 USAKingman, Linda S.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Dept Med, Lebanon, NH 03756 USAKinlaw, William B.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Dept Med, Lebanon, NH 03756 USARhodes, C. Harker论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Dept Med, Lebanon, NH 03756 USAEskey, Clifford J.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Dept Med, Lebanon, NH 03756 USASimmons, Nathan E.论文数: 0 引用数: 0 h-index: 0机构: Dartmouth Hitchcock Med Ctr, Hematol Oncol Sect, Dept Med, Lebanon, NH 03756 USA
- [10] Treatment of macroprolactinoma with cabergoline: A study of 85 patients[J]. CLINICAL ENDOCRINOLOGY, 1997, 46 (04) : 409 - 413Ferrari, CI论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYAbs, R论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYBevan, JS论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYBrabant, G论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYCiccarelli, E论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYMotta, T论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYMucci, M论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYMaratori, M论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYMusatti, L论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYVerbessem, G论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALYScanlon, MF论文数: 0 引用数: 0 h-index: 0机构: S PIO X HOSP,DEPT MED,MILAN,ITALY